Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2025 16:30 ET | Source: CVRx, Inc.

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that it plans to release first quarter 2025 financial...
April 07, 2025 16:05 ET | Source: CVRx, Inc.

CVRx Reports Preliminary First Quarter 2025 Financial Results

MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025...
February 12, 2025 14:45 ET | Source: CVRx, Inc.

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

MINNEAPOLIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the presentation of new real-world evidence at the...
February 04, 2025 16:05 ET | Source: CVRx, Inc.

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
January 21, 2025 16:30 ET | Source: CVRx, Inc.

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
January 13, 2025 08:00 ET | Source: CVRx, Inc.

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance

Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to be $51.1 million to $51.2 million, representing growth of 30%Fiscal 2025...
December 23, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43rd Annual...
November 20, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

MINNEAPOLIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Piper...
November 04, 2024 08:00 ET | Source: CVRx, Inc.

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services...
October 29, 2024 16:05 ET | Source: CVRx, Inc.

CVRx Reports Third Quarter 2024 Financial and Operating Results

MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...